The m6A writer WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase the stability of Parkinson’s protein 7 (PARK7) [98]. Here, PARK7 is linked to hepatocellular carcinoma.